Mifepristone treatment of chronic central serous chorioretinopathy

Jared S. Nielsen; Robert N. Weinreb; Lawrence Yannuzzi; Lee Merrill Jampol

doi:10.1097/IAE.0b013e3180316fd8

Mifepristone treatment of chronic central serous chorioretinopathy

Jared S. Nielsen, Robert N. Weinreb, Lawrence Yannuzzi, Lee Merrill Jampol^*

^*Corresponding author for this work

Ophthalmology

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

Antiglucocorticoid therapy has been hypothesized to be beneficial in the treatment of central serous chorioretinopathy (CSC). We report a case of severe chronic CSC with a favorable response to oral mifepristone, a potent antiglucocorticoid medication.

Original language	English (US)
Pages (from-to)	119-122
Number of pages	4
Journal	Retina
Volume	27
Issue number	1
DOIs	https://doi.org/10.1097/IAE.0b013e3180316fd8
State	Published - Jan 1 2007

ASJC Scopus subject areas

Ophthalmology
Sensory Systems

Access to Document

10.1097/IAE.0b013e3180316fd8

Cite this

@article{7dca1d25faa54f34b8466b072ee31b69,

title = "Mifepristone treatment of chronic central serous chorioretinopathy",

abstract = "Antiglucocorticoid therapy has been hypothesized to be beneficial in the treatment of central serous chorioretinopathy (CSC). We report a case of severe chronic CSC with a favorable response to oral mifepristone, a potent antiglucocorticoid medication.",

author = "Nielsen, {Jared S.} and Weinreb, {Robert N.} and Lawrence Yannuzzi and Jampol, {Lee Merrill}",

year = "2007",

month = jan,

day = "1",

doi = "10.1097/IAE.0b013e3180316fd8",

language = "English (US)",

volume = "27",

pages = "119--122",

journal = "Retina",

issn = "0275-004X",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Mifepristone treatment of chronic central serous chorioretinopathy

AU - Nielsen, Jared S.

AU - Weinreb, Robert N.

AU - Yannuzzi, Lawrence

AU - Jampol, Lee Merrill

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Antiglucocorticoid therapy has been hypothesized to be beneficial in the treatment of central serous chorioretinopathy (CSC). We report a case of severe chronic CSC with a favorable response to oral mifepristone, a potent antiglucocorticoid medication.

AB - Antiglucocorticoid therapy has been hypothesized to be beneficial in the treatment of central serous chorioretinopathy (CSC). We report a case of severe chronic CSC with a favorable response to oral mifepristone, a potent antiglucocorticoid medication.

UR - http://www.scopus.com/inward/record.url?scp=33846239926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846239926&partnerID=8YFLogxK

U2 - 10.1097/IAE.0b013e3180316fd8

DO - 10.1097/IAE.0b013e3180316fd8

M3 - Article

C2 - 17218929

AN - SCOPUS:33846239926

SN - 0275-004X

VL - 27

SP - 119

EP - 122

JO - Retina

JF - Retina

IS - 1

ER -

Mifepristone treatment of chronic central serous chorioretinopathy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this